The almost exclusively tumor-specific CA9, whose gene is induced by the hypoxia-inducible factor-1α, is a transmembrane enzyme aimed at controlling intracellular pH changes that result from the accumulation of acidic metabolites under hypoxic conditions. This evidence concerns the gene CA9 and neoplasm.